Mason Street Advisors’s Cantel Medical Corporation CMD Stock Holding History

Mason Street Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,080	Closed	-$1.58M	–	1436
2020 Q4	$1.58M	Hold	20,080	–	–	0.03%	738
2020 Q3	$882K	Sell	20,080 -248	-1%	-$12.2K	0.02%	870
2020 Q2	$899K	Buy	20,328 +399	+2%	+$14.9K	0.02%	864
2020 Q1	$715K	Hold	19,929	–	–	0.02%	859
2019 Q4	$1.41M	Buy	19,929 +655	+3%	+$47.5K	0.03%	766
2019 Q3	$1.44M	Sell	19,274 -95	-0.5%	-$8.05K	0.03%	710
2019 Q2	$1.56M	Buy	19,369 +67	+0.3%	+$4.71K	0.03%	682
2019 Q1	$1.29M	Buy	19,302 +289	+2%	+$21.9K	0.03%	795
2018 Q4	$1.42M	Buy	19,013 +376	+2%	+$31K	0.03%	661
2018 Q3	$1.72M	Buy	18,637 +454	+2%	+$43.2K	0.04%	658
2018 Q2	$1.79M	Buy	18,183 +335	+2%	+$37.5K	0.04%	620
2018 Q1	$1.99M	Buy	17,848 +8,577	+93%	+$961K	0.05%	527
2017 Q4	$954K	Buy	9,271 +289	+3%	+$28.8K	0.02%	858
2017 Q3	$846K	Buy	8,982 +30	+0.3%	+$2.37K	0.02%	873
2017 Q2	$697K	Buy	8,952 +465	+5%	+$34.9K	0.02%	906
2017 Q1	$680K	Buy	8,487 +556	+7%	+$44.2K	0.02%	906
2016 Q4	$625K	Buy	7,931 +462	+6%	+$35.9K	0.02%	913
2016 Q3	$582K	Buy	7,469 +458	+7%	+$33.2K	0.02%	906
2016 Q2	$482K	Buy	7,011 +635	+10%	+$43.8K	0.01%	923
2016 Q1	$455K	Buy	6,376 +609	+11%	+$38.2K	0.01%	919
2015 Q4	$358K	Buy	5,767 +503	+10%	+$30.7K	0.01%	949
2015 Q3	$298K	Buy	5,264 +386	+8%	+$20.4K	0.01%	971
2015 Q2	$262K	Buy	4,878 +191	+4%	+$9.29K	0.01%	1007
2015 Q1	$223K	Buy	4,687 +146	+3%	+$6.46K	0.01%	1049
2014 Q4	$196K	Buy	4,541 +152	+3%	+$6.21K	﹤0.01%	1505
2014 Q3	$151K	Buy	4,389 +176	+4%	+$6.22K	﹤0.01%	1555
2014 Q2	$154K	Buy	4,213 +128	+3%	+$4.34K	﹤0.01%	1552
2014 Q1	$138K	Sell	4,085 -1,215	-23%	-$40.1K	﹤0.01%	1547
2013 Q4	$180K	Buy	5,300 +415	+8%	+$14.4K	﹤0.01%	1539
2013 Q3	$156K	Buy	4,885 +389	+9%	+$10.3K	﹤0.01%	1387
2013 Q2	$102K	Buy	+4,496	New	+$97.3K	﹤0.01%	1431

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Mason Street Advisors's CMD Position: Q1 2021 in Review

Mason Street Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 20,080 shares — an estimated $1.58M sold.

Mason Street Advisors first reported a position in CMD in Q2 2013 and held it in 31 quarters. The position peaked at $1.99M in Q1 2018. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

Mason Street Advisors reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
Mason Street Advisors sold 20,080 Cantel Medical Corporation shares in Q1 2021, an estimated $1.58M.
Mason Street Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 31 quarters.
Mason Street Advisors's Cantel Medical Corporation position peaked at $1.99M in Q1 2018.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.